Canadian National Railway Co. vs Enveric Biosciences Inc — how do they compare? Canadian National Railway Co. trades at $126.3 (market cap $76.28B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: Canadian National Railway Co. is far larger — about 12303.2× Enveric Biosciences Inc's market cap, and Canadian National Railway Co. pays a 2.06% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| CNI | ENVB | |
|---|---|---|
Market Cap | $76.28B | $6.20M |
Sector | Industrials | Health |
52-Week High | $130.58 | $17.40 |
52-Week Low | $90.91 | $1.27 |
Enterprise Value | $92.31B | $1.30M |
Dividend Yield | 2.06% | — |
Trailing returns across standard periods
Canadian National's railway spans Canada from coast to coast and extends through Chicago to the Gulf of Mexico. In 2019, CN delivered almost 6 million carloads over its 19,600 miles of track. CN generated roughly CAD 14 billion in total revenue by hauling intermodal containers (25% of consolidated revenue), petroleum and chemicals (21%), grain and fertilizers (16%), forest products (12%), metals and mining (11%), automotive shipments (6%), and coal (4%). Other items constitute the remaining revenue.
Read more on CNI →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →